Related Experiment Video
Updated: Feb 14, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Targeting cancer stem cells in the clinic: Current status and perspectives
Stephanie Annett1, Tracy Robson1
1Molecular and Cellular Therapeutics, Royal College of Surgeons Ireland, Ireland.
Abstract:
Resistance to chemotherapy and cancer relapse are major clinical challenges attributed to a sub population of cancer stem cells (CSCs). The concept of CSCs has been the subject of intense research by the oncology community since evidence for their existence was first published over twenty years ago. Emerging data indicates that they are also able to evade novel therapies such as targeted agents, immunotherapies and anti-angiogenics. The inability to appropriately identify and isolate CSCs is a major hindrance to the field and novel technologies are now being utilized. Agents that target CSC-associated cell surface receptors and signaling pathways have generated promising pre-clinical results and are now entering clinical trial. Here we discuss and evaluate current therapeutic strategies to target CSCs.
Insights
Cancer stem cells (CSCs) drive treatment resistance and relapse. Targeting CSCs via cell surface receptors and signaling pathways shows promise for new cancer therapies.
Area of Science:
- Oncology
- Cancer Biology
- Translational Medicine
Background:
- Cancer stem cells (CSCs) are implicated in chemotherapy resistance and tumor relapse, posing significant clinical challenges.
- CSCs can evade various novel therapeutic strategies, including targeted agents, immunotherapies, and anti-angiogenics.
- Identifying and isolating CSCs remains a major hurdle in cancer research and treatment development.
Purpose of the Study:
- To review and evaluate current therapeutic strategies aimed at targeting cancer stem cells (CSCs).
- To discuss the challenges and advancements in identifying and isolating CSCs for therapeutic development.
Main Methods:
- Review of existing literature on cancer stem cell biology and therapeutic targeting.
- Evaluation of pre-clinical and clinical data for agents targeting CSCs.
- Discussion of novel technologies for CSC identification and isolation.
Main Results:
- Agents targeting CSC-associated cell surface receptors and signaling pathways have shown promising pre-clinical results.
- Several CSC-targeting agents are advancing into clinical trials.
- Novel technologies are being employed to overcome challenges in CSC identification and isolation.
Conclusions:
- Targeting cancer stem cells is a critical strategy to overcome treatment resistance and prevent cancer relapse.
- Advancements in CSC identification and therapeutic targeting offer new hope for improved cancer patient outcomes.
- Further clinical investigation of CSC-targeting agents is warranted.
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Clinical Applications of Epidermal Stem Cells
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Adult Stem Cells

